BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31017454)

  • 1. Biobank Continuity Management: A Survey of Biobank Professionals.
    Church TD; Richmond FJ
    Biopreserv Biobank; 2019 Oct; 17(5):410-417. PubMed ID: 31017454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical Financial Challenges for Biobanking: Report of a National Cancer Institute Study.
    Rao A; Vaught J; Tulskie B; Olson D; Odeh H; McLean J; Moore HM
    Biopreserv Biobank; 2019 Apr; 17(2):129-138. PubMed ID: 30638412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing Professionalization of Biobank Business Operations: A Worldwide Survey.
    Henderson MK; Goldring K; Simeon-Dubach D
    Biopreserv Biobank; 2019; 17(1):71-75. PubMed ID: 30412417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crisis Management for Biobanks.
    Parry-Jones A; Hansen J; Simeon-Dubach D; Bjugn R
    Biopreserv Biobank; 2017 Jun; 15(3):253-263. PubMed ID: 27977307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Forward-Thinking" in U.S. Biobanking.
    Cadigan RJ; Edwards TP; Lassiter D; Davis AM; Henderson GE
    Genet Test Mol Biomarkers; 2017 Mar; 21(3):148-154. PubMed ID: 28118036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing Professionalization of Biobank Business Operations: Performance and Utilization.
    Henderson MK; Goldring K; Simeon-Dubach D
    Biopreserv Biobank; 2019 Jun; 17(3):213-218. PubMed ID: 31188630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating Biobanks.
    Ling R; Rush A; Carter C; Carpenter J; Watson PH; Byrne JA; Searles A
    Biopreserv Biobank; 2018 Feb; 16(1):53-58. PubMed ID: 29215912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biobank classification in an Australian setting.
    Rush A; Christiansen JH; Farrell JP; Goode SM; Scott RJ; Spring KJ; Byrne JA
    Biopreserv Biobank; 2015 Jun; 13(3):212-8. PubMed ID: 26035012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ISO 20387 biobanking standard. Analysis of requirements and experience of implementation.
    Borisova AL; Pokrovskaya MS; Meshkov AN; Metelskaya VA; Shatalova AM; Drapkina OM
    Klin Lab Diagn; 2020 Sep; 65(9):587-592. PubMed ID: 33245646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and Driving Forces for Business Plans in Biobanking.
    Macheiner T; Huppertz B; Bayer M; Sargsyan K
    Biopreserv Biobank; 2017 Apr; 15(2):121-125. PubMed ID: 28338345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How is your biobank handling disaster recovery efforts?
    Baird PM; Benes FM; Chan CH; Eng CB; Groover KH; Prodanovic Z; Rawley-Payne M; Kizza R; Hia C; Abouhamze A
    Biopreserv Biobank; 2013 Aug; 11(4):194-201. PubMed ID: 24845584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traditional and electronic informed consent for biobanking: a survey of U.S. biobanks.
    Simon CM; Klein DW; Schartz HA
    Biopreserv Biobank; 2014 Dec; 12(6):423-9. PubMed ID: 25496155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A strategic plan for the second phase (2013-2015) of the Korea biobank project.
    Park O; Cho SY; Shin SY; Park JS; Kim JW; Han BG
    Osong Public Health Res Perspect; 2013 Apr; 4(2):107-16. PubMed ID: 24159540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Business Planning for a Campus-Wide Biobank.
    Tarling TE; Lasser F; Carter C; Matzke LA; Dhugga G; Arora N; Dee S; LeBlanc J; Babinsky S; O'Donoghue S; Cheah S; Watson P; Vercauteren SM
    Biopreserv Biobank; 2017 Feb; 15(1):37-45. PubMed ID: 28151006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality management in biobank. World tendencies and experience of biobank of FSI «NMRC for preventive medicine» of the Ministry of healthcare of Russia.].
    Pokrovskaya MS; Borisova AL; Sivakova OV; Metelskaya VA; Meshkov AN; Shatalova AM; Drapkina OM
    Klin Lab Diagn; 2019; 64(6):380-384. PubMed ID: 31200412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. US and Scottish health professionals' attitudes toward DNA biobanking.
    Leiman DA; Lorenzi NM; Wyatt JC; Doney AS; Rosenbloom ST
    J Am Med Inform Assoc; 2008; 15(3):357-62. PubMed ID: 18308988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Best practices for establishing a biobank.
    Hallmans G; Vaught JB
    Methods Mol Biol; 2011; 675():241-60. PubMed ID: 20949394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Survey of the Current Situation of Clinical Biobanks in China.
    Li H; Ni M; Wang P; Wang X
    Biopreserv Biobank; 2017 Jun; 15(3):248-252. PubMed ID: 28080144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a Synergistic Operating Model for Westmead Research Hub Biobanks: A Questionnaire Study.
    St George G; Wang XM; Linton J; Douglas N; Carpenter JE; Clarke CL; Heads JA
    Biopreserv Biobank; 2019 Dec; 17(6):570-576. PubMed ID: 31429584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Position Statement from the German Biobank Alliance on the Cooperation Between Academic Biobanks and Industry Partners.
    Baber R; Hummel M; Jahns R; von Jagwitz-Biegnitz M; Kirsten R; Klingler C; Nussbeck SY; Specht C
    Biopreserv Biobank; 2019 Aug; 17(4):372-374. PubMed ID: 31314575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.